Summary
Permanent lymphoblastoid cell lines are of great practical value in human clinical and experimental genetics. A detailed protocol for routine use is given for the establishment of lymphoblastoid lines from peripheral blood using Esptein-Barr virus and the immunosuppressivum Cyclosporin A. In addition, the biologic basis of this transformation system is briefly summarized.
Similar content being viewed by others
References
Aya T, Osato T (1974) Early events in transformation of human cord leukocytes by Epstein-Barr virus: induction of DNA synthesis, mitosis and the virus-associated nuclear antigen synthesis. Int J Cancer 14:341–347
Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, Barrell BG (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207–211
Bird AG, McLachlan SM, Britten S (1981a) Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature 289:300–301
Bird AG, Britten S, Ernberg I, Nilsson K (1981b) Characteristics of Epstein-Barr virus activation of human B lymphocytes. J Exp Med 154:832–839
Bodescot M, Chambraud B, Farrell P, Perricaudet M (1984) Spliced RNA from the IR1-U2 region of Epstein-Barr virus: presence of an open reading frame for a repetitive polypeptide. EMBO J 3: 1913–1917
Brack C, Mattaj IW, Gautschi J, Cammisuli S (1984) Cyclosporin A is a differential inhibitor of eukaryotic RNA polymerases. Exp Cell Res 151:314–321
Cohen LK, Speck SH, Roberts BE, Strominger JL (1984) Identification and mapping of polypeptides encoded by the P3HR-1 strain of Epstein-Barr virus. Proc Natl Acad Sci USA 81:4183–4187
Dambaugh T, Beisel C, Hummel M, King W, Fennewald S, Cheung A, Heller M, Raab-Traub N, Kieff E (1980) Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping. Proc Natl Acad Sci USA 77:2999–3003
Einhorn L, Ernberg I (1978) Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes. Int J Cancer 21:157–160
Henderson E, Miller G, Robinson J, Heston L (1977) Efficiency of transformation of lymphocytes by Epstein-Barr virus. Virology 76:152–163
Henderson A, Ripley S, Heller M, Kieff E (1983) Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proc Natl Acad Sci USA 80:1987–1991
Ikeuchi T (1984) Inhibitory effect of ethidium bromide on mitotic chromosome condensation and its application to high-resolution chromosome banding. Cytogenet Cell Genet 38:56–61
Issekutz T, Chu E, Geha RS (1982) Antigen presentation by human B cells: T cell proliferation induced by Epstein-Barr virus B lymphoblastoid cells. J Immunol 129:1446–1450
James SP, Yenokida GG, Graeff AS, Strober W (1982) Activation of suppressor T cells by autologous lymphoblastoid cells: a mechanism for feedback regulation of immunoglobulin synthesis. J Immunol 128:1149–1154
Kirchner H, Tosato G, Blaese RM, Broder S, Magrath IT (1979) Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro. J Immunol 122:1310–1313
Klein G, Sugden B, Leibold W, Menezes J (1974) Infection of EBV-genome-negative and positive human lymphoblastoid cell lines with biologically different preparations of EBV. Intervirology 3:232–244
Krönke M, Leonard WJ, Depper JM, Arya SK, Wong-Staal F, Gallo RC, Waldmann TA, Greene WC (1984) Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci USA 81:5214–5218
Miller G (1984) Epstein-Barr virus—immortalization and replication. N Engl J Med 310:1255–1256
Miller G, Lipman M (1973) Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus. J Exp Med 138:1398–1412
Moss DJ, Rickinson AB, Pope JH (1978) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer 22:662–668
Moss DJ, Rickinson AB, Pope JH (1979) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures. Int J Cancer 23:618–625
Moss DJ, Rickinson AB, Wallace LE, Epstein MA (1981) Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation. Nature 291:644–666
Nowell PC (1960) Phytohemagglutinin: An indicator of mitosis in cultures of normal human leukocytes. Cancer Res 20:462–466
Palacios R (1981) Cyclosporin A abrogates proliferation of T cells and generation of suppressor and cytotoxic T-cell function induced by Epstein-Barr virus. Immunbiology 160:321–329
Pattengale PK, Smith RW, Gerber P (1973) Selective transformation of B lymphocytes by EB virus. Lancet II:93–94
Pizzo PA, Magrath IT, Chattopadhyay SK, Biggar RJ, Gerber P (1978) A new tumor-derived transforming strain of Epstein-Barr virus. Nature 272:629–631
Rabin H, Neubauer RH, Hopkins RF, Nonoyama M (1978) Further characterization of a Herpes virus-positive orang-utan cell line and comparative aspects of in vitro transformation with lymphotropic old world primate Herpes viruses. Int J Cancer 21:762–767
Rickinson A (1984) Epstein-Barr virus in epithelium. Nature 310:99
Rickinson AB, Moss DJ, Pope JH (1979) Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures. Int J Cancer 23:610–617
Rickinson AB, Moss DJ, Allen DJ, Wallace LE, Rowe M, Epstein MA (1981) Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line. Int J Cancer 27:593–601
Robinson J, Smith D (1981) Infection of human B lymphocytes with high multiplicities of Epstein-Barr virus: kinetics of EBNA expression, cellular DNA synthesis, and mitosis. Virology 109:336–343
Robinson J, Frank A, Henderson E, Schweitzer J, Miller G (1979) Surface markers and size of lymphocytes in human umbilical cord blood stimulated into deoxyribonucleic acid synthesis by Epstein-Barr virus. Infect Immun 26:225–231
Schneider U, zur Hausen H (1975) Epstein-Barr virus-induced transformation of human leukocytes after cell fractionation. Int J Cancer 15:59–66
Schooley RT, Haynes BF, Payling-Wright CR, Grouse JE, Dolin R, Fauci AS (1980) Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation. Cell Immunol 56:518–525
Sixbey JW, Vesterinen EH, Nedrud JG, Raab-Traub N, Walton LA, Pagano JS (1983) Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 306:480–483
Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS (1984) Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310:1225–1230
Steel CM, Philipson J, Arthur E, Gardiner SE, Newton MS, McIntosh RV (1977) Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes. Nature 270:729–730
Sugden B, Mark W (1977) Clonal transformation of adult human leukocytes by Epstein-Barr virus. J Virol 23:503–508
Sudgen B, Phelps M, Domoradzki J (1979) Epstein-Barr virus DNA is amplified in transformed lymphocytes. J Virol 31:590–595
Szigeti R, Sulitzeanu D, Henle G, Henle W, Klein G (1984) Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody. Proc Natl Acad Sci USA 81:4178–4182
Takadá K, Osato T (1979) Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis. Intervirology 11:30–39
Tanaka Y, Sugamura K, Hinuma Y, Sato H, Okochi K (1980) Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropositive adults as revealed by an in vitro restimulation method. J Immunol 125:1426–1431
Tosato G, Pike SE, Koski IR, Blaese RM (1982a) Selective inhibition of immunoregulatory cell functions by Cyclosporin A. J Immunol 128:1986–1991
Tosato G, Magrath IT, Blaese RM (1982b) T cell-mediated immunoregulation of Epstein-Barr virus (EBV)-induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. J Immunol 128:575–579
Tsukuda K, Tsukuda Y, Klein G (1982) Suppressor T cells activated by autologous B-cell derived lines inhibit blastogenic responses by peripheral lymphocytes to mitogens or autologous lymphoblastoid cell lines. Cell Immunol 69:291–304
Werner J, Henle G, Pinto CA, Haff RF, Henle W (1972) Establishment of continuous lymphoblast cultures from leukocytes of gibbons (Hylobates lar). Int J Cancer 10:557–567
Wolf H (1984) Epstein-Barr virus and carcinoma. Nature 312:705
Wolf H, Haus M, Wilmes E (1984) Persistence of Epstein-Barr virus in the parotid gland. J Virol 51:795–798
Yamamoto K, Mizuno F, Matsuo T, Tanaka A, Nonoyama M, Osato T (1978) Epstein-Barr virus and human chromosomes: close association of the resident viral genome and the expression of the virus-determined nuclear antigen (EBNA) with the presence of chromosome 14 in human-mouse hyrid cells. Proc Natl Acad Sci USA 75:5155–5159
Yates J, Warren N, Reisman D, Sugden B (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 81:3806–3810
Yunis JJ, Sawyer JR, Ball DW (1978) The characterization of highresolution G-banded chromosomes of man. Chromosoma 67: 293–307
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neitzel, H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 73, 320–326 (1986). https://doi.org/10.1007/BF00279094
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00279094